INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 07/07/2025 at 22:05, 4 months 28 days ago

Inventiva Receives $10 Million Milestone Payment from CTTQ

Milestone Payment Lanifibranor Biopharmaceutical Development MASH Treatment CTTQ Partnership
PRESS RELEASE

published on 07/07/2025 at 22:00, 4 months 28 days ago

Inventiva receives $10 million milestone payment from CTTQ
Inventiva receives $10 million milestone payment from CTTQ following successful structured financing. Partnership aims to develop lanifibranor for MASH treatment in Chinese regions

Inventiva Milestone Payment MASH Lanifibranor CTTQ
BRIEF

published on 07/02/2025 at 22:05, 5 months 2 days ago

Inventiva Publishes Promising Results on Lanifibranor for Liver Disease

Phase 2b Study Liver Disease Lanifibranor MASH Treatment Journal Of Hepatology Reports
PRESS RELEASE

published on 07/02/2025 at 22:00, 5 months 2 days ago

Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease
Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits

Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization
BRIEF

published on 06/10/2025 at 22:05, 5 months 24 days ago

Renée Aguiar-Lucander Joins Inventiva's Board of Directors

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
PRESS RELEASE

published on 06/10/2025 at 22:00, 5 months 24 days ago

Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors
Inventiva appoints Renée Aguiar-Lucander to its Board of Directors. Aguiar-Lucander brings extensive industry experience and leadership to the company

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
BRIEF

published on 05/27/2025 at 22:05, 6 months 8 days ago

Inventiva at the Jefferies and UBS Healthcare Conferences

Biopharmaceuticals Inventiva MASH UBS Conference Jefferies Conference
PRESS RELEASE

published on 05/27/2025 at 22:00, 6 months 8 days ago

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City

Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF

published on 05/23/2025 at 08:35, 6 months 13 days ago

Inventiva Reports First Quarter 2025 Financials: Cash Position Declines

Financial Results Cash Position Clinical Trial Inventiva Lanifibranor
PRESS RELEASE

published on 05/23/2025 at 08:30, 6 months 13 days ago

Inventiva reports 2025 First Quarter Financial Information¹
Inventiva reports €67.9 million in cash and cash equivalents for Q1 2025. Forecasted funds to support operations until Q3 2026. Key milestones include Phase 3 trial results expected in late 2026

Financial Information Inventiva Q1 2025 Cash Equivalents NATiV3 Trial

Accesswire

Published on 12/05/2025 at 14:00, 54 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 54 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 19 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 24 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 54 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 31 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 37 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 43 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 8 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 54 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 08:45, 6 hours 9 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 54 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 9 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 10 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE